<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04206449</url>
  </required_header>
  <id_info>
    <org_study_id>PI17/02011</org_study_id>
    <nct_id>NCT04206449</nct_id>
  </id_info>
  <brief_title>Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA)</brief_title>
  <acronym>TERMOAPNEA</acronym>
  <official_title>Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (OSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Araba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ibermática/i3B</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bioraba</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario Araba</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the diagnostic validity and cost-effectiveness of an infrared thermography system
      in adults with clinical suspicion of Obstructive Sleep Apnea (OSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      AIMS: To assess the diagnostic validity and cost-effectiveness of an infrared thermography
      system, integrated in an expert diagnostic algorithm (TIS), to determine the sleep stages and
      identify respiratory events, compared to conventional polysomnography (PSG) in adults with
      clinical suspicion of Obstructive Sleep Apnea (OSA).

      METODOLOGY: DESIGN: Prospective, unicentric, randomized and blinded study carried out into
      two phases: Phase I: Development of the tool in 99 full valuable adults with suspected OSA
      (PSG recruitment, coordination and quality control, image capture, Information and
      development of the expert system); Phase II: Validation of the tool compared with the PSG in
      another group of 99 full valuable adults with suspected OSA. INSTRUMENTALIZATION: a) Clinical
      history and anthropometric variables; b) Sleep and quality of life questionnaires; c) PSG; d)
      TIS; e) Cost-effectiveness study.

      ANALYSYS : The validity of the results of the TIS will be analyzed compared with the results
      of the PSG. The agreement measure will be established according to the different categories
      of the Apnea-Hypopnea Index (AHI), using ROC (Receiver Operating Characteristic) curves and
      the area under the curve. The investigators will also validate the therapeutic decisions made
      with PSG compared to those performed with the TIS. Finally, a cost-effectiveness study will
      be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2018</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index (AHI)</measure>
    <time_frame>Baseline</time_frame>
    <description>Count the respiratory events (apneas and hypopneas) that occur during sleep using a high sensitivity infrared thermal camera integrated in an expert diagnostic algorithm (TIS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Validation of the therapeutic decision</measure>
    <time_frame>6 month</time_frame>
    <description>Analyze the concordance in the therapeutic decision using clinical findings and the results of Apnea-Hypopnea Index (AHI) from standard polysomnography (PSG) compared with data from infrared thermography system. In the Phase II.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness analysis</measure>
    <time_frame>6 month</time_frame>
    <description>Cost-efficacy evaluation: the analysis will be made in both arms based on intention to treat. Only direct costs will be analyzed: the cost of the use of polysomnography and infrared thermography system (Staff and consumable material).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>The Epworth Sleepiness Scale (the sum of 8 items score,0-3) can range from 0 to 24. Scores of 11-24 represent increasing levels of excessive daytime sleepiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STOP-Bang Questionnaire</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>The questionnaire screens for obstructive sleep apnea (OSA):
Low risk of OSA: &lt;3
High risk of OSA: ≥3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Berlin questionnaire</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>The questionnaire consists of 3 categories related to the risk of having sleep apnea. Patients can be classified into High Risk or Low Risk based on their responses to the individual items and their overall scores in the symptom categories.
High Risk: if there are 2 or more categories where the score is positive.
Low Risk: if there is only 1 or no categories where the score is positive.
Scoring Categories:
Category 1 is positive with 2 or more positive responses to questions 2-6
Category 2 is positive with 2 or more positive responses to questions 7-9
Category 3 is positive with 1 positive response and a BMI&gt;30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>Blood pressure measurements: systolic blood pressure and diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric variables (Body mass index)</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>Body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (EuroQOL test)</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>Evaluate by EuroQOL test, is a standardised measure of health status. Description of the state of health in five dimensions (mobility, self-car, usual activities, pain/discomfort and anxiety/depression), each o wich is defined with three levels of severity, as measured by a Likert scale type (no problems, some problems and many problems or inability to activity).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">198</enrollment>
  <condition>Obstructive Sleep Apnea (OSA)</condition>
  <arm_group>
    <arm_group_label>Infrared thermography system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Therapeutic decision taken with infrared thermography system, integrated in an expert diagnostic algorithm (TIS), to determine the sleep stages and Apnea-Hypopnea Index (AHI).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Polysomnography (PSG)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Therapeutic decision taken with Standard Polysomnography (PSG), to determine the sleep stages and Apnea-Hypopnea Index (AHI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Therapeutic decision</intervention_name>
    <description>Randomizing for therapeutic decision taken with Standard Polysomnography (PSG) or Infrared thermography system</description>
    <arm_group_label>Infrared thermography system</arm_group_label>
    <arm_group_label>Standard Polysomnography (PSG)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women over 18 years to 75 years old, with clinical suspicion of OSA

          -  Written informed consent signed

        Exclusion Criteria:

          -  Place of residence more than 100 km from the hospital

          -  Severe, unstable or exacerbated cardio-vascular, cerebro-vascular or respiratory
             disease, that makes it impossible to carry out adequate studies

          -  Presence of insomnia, depressive syndrome or epilepsia

          -  Patients diagnosed of any acute inflammatory episode of the cranium-maxillo-facial
             area or any systemic infection that develops with fever&gt; 38 ºC at the time of testing

          -  Patient with malformation syndromes, Down syndrome and neuromuscular diseases

          -  Patient on active treatment with Positive continuous pressure (CPAP )
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaquin Duran-Cantolla, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario Araba</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joaquin Duran-Cantolla, MD</last_name>
    <phone>+34945007043</phone>
    <email>joaquin.durancantolla@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Araba</name>
      <address>
        <city>Gasteiz / Vitoria</city>
        <state>Araba</state>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joaquin Duran-Cantolla, MD</last_name>
      <phone>+34945007043</phone>
      <email>joaquin.durancantolla@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Durán-Cantolla J, Puertas FJ, Pin G y el Grupo Español de Sueño (GES).Documento de consenso nacional sobre el SAHS. Arch Bronconumol 2005;41(nº4):1-110.</citation>
  </reference>
  <reference>
    <citation>Lloberes P, Durán-Cantolla J, Martínez-García MÁ, Marín JM, Ferrer A, Corral J, Masa JF, Parra O, Alonso-Álvarez ML, Terán-Santos J. Diagnosis and treatment of sleep apnea-hypopnea syndrome. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol. 2011 Mar;47(3):143-56. doi: 10.1016/j.arbres.2011.01.001. English, Spanish. Erratum in: Arch Bronconeumol. 2011 Jul;47(7):378.</citation>
    <PMID>21398016</PMID>
  </reference>
  <reference>
    <citation>Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):685-9.</citation>
    <PMID>11254524</PMID>
  </reference>
  <reference>
    <citation>Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230-5.</citation>
    <PMID>8464434</PMID>
  </reference>
  <reference>
    <citation>Durán-Cantolla J, Mar J, de La Torre Muñecas G, Rubio Aramendi R, Guerra L. [The availability in Spanish public hospitals of resources for diagnosing and treating sleep apnea-hypopnea syndrome]. Arch Bronconeumol. 2004 Jun;40(6):259-67. Spanish.</citation>
    <PMID>15161592</PMID>
  </reference>
  <reference>
    <citation>Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, Rapoport DM, Redline S, Resnick HE, Robbins JA, Shahar E, Unruh ML, Samet JM. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009 Aug;6(8):e1000132. doi: 10.1371/journal.pmed.1000132. Epub 2009 Aug 18.</citation>
    <PMID>19688045</PMID>
  </reference>
  <reference>
    <citation>Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ, Hudgel D, Sateia M, Schwab R; Portable Monitoring Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2007 Dec 15;3(7):737-47.</citation>
    <PMID>18198809</PMID>
  </reference>
  <reference>
    <citation>Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005 Apr;28(4):499-521. Review.</citation>
    <PMID>16171294</PMID>
  </reference>
  <reference>
    <citation>Mulgrew AT, Fox N, Ayas NT, Ryan CF. Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study. Ann Intern Med. 2007 Feb 6;146(3):157-66.</citation>
    <PMID>17283346</PMID>
  </reference>
  <reference>
    <citation>Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009 Jun 15;5(3):263-76.</citation>
    <PMID>19960649</PMID>
  </reference>
  <reference>
    <citation>Van Someren EJ. More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities. Chronobiol Int. 2000 May;17(3):313-54. Review.</citation>
    <PMID>10841209</PMID>
  </reference>
  <reference>
    <citation>Parmeggiani PL. Thermoregulation during sleep from the view point of homeostasis. Clinical Physiology of Sleep, American Physiological Society 1988, pp 159-69.</citation>
  </reference>
  <reference>
    <citation>van den Heuvel CJ, Noone JT, Lushington K, Dawson D. Changes in sleepiness and body temperature precede nocturnal sleep onset: evidence from a polysomnographic study in young men. J Sleep Res. 1998 Sep;7(3):159-66.</citation>
    <PMID>9785270</PMID>
  </reference>
  <reference>
    <citation>Gilbert SS, van den Heuvel CJ, Ferguson SA, Dawson D. Thermoregulation as a sleep signalling system. Sleep Med Rev. 2004 Apr;8(2):81-93. Review.</citation>
    <PMID>15033148</PMID>
  </reference>
  <reference>
    <citation>Raymann RJ, Swaab DF, Van Someren EJ. Skin temperature and sleep-onset latency: changes with age and insomnia. Physiol Behav. 2007 Feb 28;90(2-3):257-66. Epub 2006 Oct 27. Review.</citation>
    <PMID>17070562</PMID>
  </reference>
  <reference>
    <citation>Parmeggiani PL, Agnati LF, Zamboni G, Cianci T. Hypothalamic temperature during the sleep cycle at different ambient temperatures. Electroencephalogr Clin Neurophysiol. 1975 Jun;38(6):589-96.</citation>
    <PMID>50184</PMID>
  </reference>
  <reference>
    <citation>Montgomery I, Trinder J, Paxton S, Harris D, Fraser G, Colrain I. Physical exercise and sleep: the effect of the age and sex of the subjects and type of exercise. Acta Physiol Scand Suppl. 1988;574:36-40.</citation>
    <PMID>3245465</PMID>
  </reference>
  <reference>
    <citation>Lack LC, Gradisar M, Van Someren EJ, Wright HR, Lushington K. The relationship between insomnia and body temperatures. Sleep Med Rev. 2008 Aug;12(4):307-17. doi: 10.1016/j.smrv.2008.02.003. Review.</citation>
    <PMID>18603220</PMID>
  </reference>
  <reference>
    <citation>van den Heuvel CJ, Ferguson SA, Dawson D, Gilbert SS. Comparison of digital infrared thermal imaging (DITI) with contact thermometry: pilot data from a sleep research laboratory. Physiol Meas. 2003 Aug;24(3):717-25.</citation>
    <PMID>14509309</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 6, 2019</study_first_submitted>
  <study_first_submitted_qc>December 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2019</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Araba</investigator_affiliation>
    <investigator_full_name>Joaquin Duran-Cantolla, MD</investigator_full_name>
    <investigator_title>Principal Investigator, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Infrared thermography system</keyword>
  <keyword>Standard Polysomnography</keyword>
  <keyword>Validity</keyword>
  <keyword>Cost-effectiveness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

